Ankle-brachial index and hemostatic markers in the atherosclerosis Risk in Communities (ARIC) study cohort

Vascular Medicine

Volumn 12, Issue 4, 2007, Pages 267-273

  Reich, Laura M ^a   Heiss, Gerardo ^b   Boland, Lori L ^a   Hirsch, Alan T ^a,c   Wu, Kenneth ^d   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Blood coagulation factors; Hemostasis; Peripheral vascular disease

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ANKLE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 38449121419     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X07082767     Document Type: Article

References (45)

1. Newman AB, Sutton-Tyrell K, Rutan GH, Locher J, Kuller LH. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 1991; 44: 15-20.
2. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2: 221-26.
3. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-92.
4. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-92.
5. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-15.
6. Fowkes FGR. Epidemiology of peripheral vascular disease. Atherosclerosis 1997; 131(suppl): S29-S31.
7. Criqui MH, Langer RD, Froneck A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-86.
8. Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25:1172-81.
9. Newman AB, Shemanski L, Manolio TA et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 538-45.
10. Assman G, Cullen P, Heinrich J, Schulte H. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Munster Heart Study (PROCAM). Prospective Cardiovascular Munster Study. Isr J Med Sci 1996; 32: 364-70.
11. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
12. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999; 19: 1776-83.
13. Folsom AR, Rosamond WD, Shahar E et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999; 100: 736-42.
14. Folsom AR, Wu KK, Rosamond WD, Sharrett A, Richey A, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 1102-108.
15. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 611-17.
16. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-37.
17. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 2001; 103: 3062-68.
18. Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87: 1915-20.
19. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 837-45.
20. Tzoulaki I, Murray GD, Price JF et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: The Edinburgh Artery Study. Am J Epidemiol 2005; 163: 334-41.
21. Allison MA, Criqui MH, McClelland RL et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48: 1190-97.
22. McDermott MM, Guralnik JM, Corsi A et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 2005; 150: 276-81.
23. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-85.
24. Philipp CS, Cisar LA, Kim HC, Wilson AC, Saidi P, Kostis JB. Association of hemostatic factors with peripheral vascular disease. Am Heart J 1997; 134: 978-84.
25. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
26. McDermott MM, Green D, Greenland P et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 194-99.
27. Aboyans V, Criqui MH, Denenberg JO et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623-29.
28. McDermott MM, Ferrucci L, Liu K et al. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005; 53: 1688-96.
29. McDermott MM, Greenland P, Green D et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003; 107: 3191-98.
30. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
31. Mundt KA, Chambless LE, Burnham CB, Heiss G. Measuring ankle systolic blood pressure: validation of the Dinamap 1846 SX. Angiology 1992; 43: 555-66.
32. Weatherley BD, Nelson JJ, Heiss G et al. The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987-2001. BMC Cardiovasc Disord 2007; 7: 3.
33. Aboyans V, Criqui MH, McClelland RL et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 2007; 45: 319-27.
34. Papp AC, Hatzakis H, Bracey AW, Wu KK. ARIC Hemostasis Study-1. Development of a blood collection and processing system suitable for multicentric studies. Thromb Haemost 1989; 61: 15-19.
35. Chambless L, McMahon R, Wu K, Folsom A, Finch A, Shin YL. Short-term intraindividual variability in hemostasis factors. The ARIC Study. Ann Epidemiol 1992; 2: 723-33.
36. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
37. ARIC Protocol Manual 9. Hemostasis determinations. Chapel Hill, NC: National Heart Lung and Blood Institute of the National Institutes of Health Collaborative Studies Coordinating Center, University of North Carolina, 1987.
38. Nguyen ND, Ghaddar H, Stinson V, Chambless LE, Wu K. ARIC Hemostasis Study-IV. Intraindividual variability and reliability of hemostasis factors. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 1995; 73: 256-60.
39. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities study. Am Heart J 2002; 144: 233-38.
40. Fowkes FGR, Lowe GDO, Housley E et al. Cross-linked fibrin degradation products and the progression of peripheral arterial disease and risk of coronary heart disease. Lancet 1993; 342: 84-86.
41. Smith FB, Lee AJ, Rumley A, Fowkes FG, Lowe GD. Tissue plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 1995; 115: 35-43.
42. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991; 146: 3032-37.
43. Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med 1966; 123: 365-78.
44. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral arterial disease. Circulation 1998; 97: 425-28.
45. Tracy RP. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 1999; 10: 435-41.